出 处:《中华老年医学杂志》2011年第10期849-853,共5页Chinese Journal of Geriatrics
基 金:国家重点基础研究发展计划(973计划)资助(2008CB517305)
摘 要:目的探讨着色性干皮病基因B(xeroderma pigmentosum B,XPB)对白介素-6(IL-6)介导入血管平滑肌细胞(VSMC)增殖及凋亡的影响。方法用脂质体转染法将重组质粒pcDNA3.1-XPB和空载质粒pcDNA3.1稳定转染VSMC,然后给予100U/ml的IL-6孵育48h。实验分为6组:(1)空白对照组;(2)peDNA3.1组;(3)pcDNA3.1-XPB组;(4)IL-6组;(5)IL-6+pcDNA3.1组;(6)IL-6+pcDNA3.1-XPB组。用反转录聚合酶链反应(RT—PCR)和蛋白质免疫印迹法(Westernblotting)检测XPB、Bcl-2、Bax和野生型p53(wt—p53)表达量的变化;用比色法(MTT)观察细胞增殖活力;用流式细胞仪检测细胞周期和凋亡率。结果重组质粒pcDNA3.1-XPB转染使细胞XPB表达增高(P〈0.05或P%0.01),同时Bcl-2表达降低、Bax和wt—p53表达增高(P〈0.05或P%0.01),抑制IL-6促进VSMC的Bcb2高表达、Bax和wt-p53降表达(P%0.05或P%0.01);XPB高表达抑制了细胞增殖活力(q=2.95,P〈0.05),并抑制IL-6促进VSMC增殖,IL-6+pcDNA3.1-XPB组和IL-6+pcDNA3.1组VSMC存活率分别为(102.6±6.2)%和(124.5±7.9)%(q=3.49,P〈0.05);流式细胞仪检测结果显示,XPB高表达引起细胞G0/G1期增加、S期减少、凋亡率增加(q值分别为2.99、5.39、3.05,P〈0.05或P〈0.01),并抑制IL-6促进VSMC G0/G1期减少、S期增加、凋亡率降低的作用,IL-6+peDNA3.1-XPB组和IL-6+peDNA3.1组分别为(70.9±6.7)%与(54.8±2.9)%、(20.2±3.6)%与(36.4±7.2)%、(5.9±2.1)%与(0.3±0.1)%(q值分别为6.91、8.54、7.53,均P〈0.01)。结论XPB基因能抑制VSMC增殖并促进其凋亡,并能抑制IL-6促进VSMC增殖和降低其凋亡的作用,有望成为治疗动脉粥样硬化的靶点。Objective To investigate effects of xeroderma pigmentosum B(XPB) gene on IL-6 induced proliferation and apoptosis in human vascular smooth muscle cells (VSMC). Methods Recombinant plasmid pcDNA3.1-XPB and vacant vector plasmid pcDNA3.1 were transfected stably into VSMC by liposome, and these ceils were incubated with IL-6 at a 100 U/ml for 48 hours. The experiments were divided into six groups: blank control group; pcDNA3.1 group; pcDNA3.1-XPB group;IL-6 group; IL-6 + pcDNA3.1 group; IL-6 + pcDNA3.1-XPB group. The expression levels of XPB, Bcl-2, Bax and wild type p53 (wt-p53) were detected through reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. The cell survival, cell cycle and apoptosis were examined with 3-( 4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and flow cytometry,respectively. Results The transfection of pcDNA3.1-XPB increased the expression of XPB, Bax and wt-p53 (P〈0.05 or P^0.01), decreased the expression of Bcl-2 (P〈0.05 or P〈 0.01), and reduced the IL-6 induced effects on decreasing the expression of Bax and wt-p53 and increasing the expression of Bcl-2(P〈0.05 or P〈0.01). The over expression of XPB inhibited the cell growth(q=2.95,P〈0.05), and reduced the positive effects of IL6 on VSMC growth(102.6± 6.2)% vs. (124. 5±7.9)%,q=3.49, P〈0.05. The over expression of XPB increased the apoptosis rate of VSMC(P〈0. 01) and the cell amounts o{ G0/G1 phase(q=2.99, P〈0.05), decreased the cell amounts of S phase(q=3.05, P〈0.05), and reduced the IL-6 induced effects on decreasing the apoptosis rate of VSMC(5. 922.1)%vs. (0. 320.1)%,q=7.53, P〈0.01; the cell amounts of G0/ G1 phase(70. 926.7)% vs. (54. 822.9)% ,q=6.91, P〈0.01 ;and on increasing the cell amounts of Sphase(20.223.6)% vs. (36.4±7.2)%,q=8.54, P〈0.01. Conclusions XPB gene could inhibit VSMC proliferation, promote VSMC apoptosis, and reduce the effects that IL-6 promotes VSMC prolife
分 类 号:R543.5[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...